Tvardi Therapeutics (TVRD) EBIT Margin (2013 - 2025)
Tvardi Therapeutics (TVRD) posted EBIT Margin of -169.48% for Q1 2025, up 1220.03 percentage points from -1389.51% a year earlier and up 572.92 percentage points from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) EBIT Margin (2013 - 2025) Analysis & Trends
For the trailing twelve months through Mar 31, 2025, EBIT Margin at Tvardi Therapeutics was -370.00%, up 359.19 percentage points year-over-year; for FY2024, it was -393.82%, up 185.61 percentage points from FY2023.
- Annual EBIT Margin shows a five-year change of +167.78 percentage points (FY2019 to FY2024).
- In prior years, Tvardi Therapeutics' EBIT Margin was -579.43% in FY2023 (-370.35 pp), -209.08% in FY2022 (+177.77 pp), -386.85% in FY2021 (-390.83 pp) and 3.99% in FY2020 (+565.58 pp).
- The Q1 2025 figure stands as the highest quarterly EBIT Margin since Q2 2022.
- On a year-over-year basis, EBIT Margin has increased in each of the last three quarters, with an average year-over-year change of -26.26 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2022, with a gain of 3123.03 percentage points; the weakest was Q4 2021, with a drop of 4152.92 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -742.41% (Q4 2024), -222.07% (Q3 2024) and -724.62% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -169.48% |
| Dec 31, 2024 | -742.41% |
| Sep 30, 2024 | -222.07% |
| Jun 30, 2024 | -724.62% |
| Mar 31, 2024 | -1,389.51% |
| Dec 31, 2023 | -1,085.45% |
| Sep 30, 2023 | -593.88% |
| Jun 30, 2023 | -466.46% |
| Mar 31, 2023 | -448.50% |
| Dec 31, 2022 | -960.04% |
| Sep 30, 2022 | -220.52% |
| Jun 30, 2022 | -19.44% |
| Mar 31, 2022 | -582.69% |
| Dec 31, 2021 | -4,083.07% |
| Sep 30, 2021 | -5.54% |
| Mar 31, 2021 | -1,217.62% |
| Dec 31, 2020 | 69.85% |
| Sep 30, 2020 | -183.68% |
| Jun 30, 2020 | -459.42% |
| Mar 31, 2020 | -370.70% |
API Access
Tvardi Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();